FDA 483 - Vitalant - February 18, 2022

Vitalant, a blood bank in Brisbane, CA, was inspected by the FDA from February 9-18, 2022. The inspection revealed one significant observation concerning the firm's failure to adhere to manufacturer instructions for a component collection system. This lapse resulted in incorrect expiration dating for irradiated red blood cell units.